COVID-19 vaccine effectiveness and evolving variants: understanding the immunological footprint
- PMID: 37080227
- PMCID: PMC10109542
- DOI: 10.1016/S2213-2600(23)00140-6
COVID-19 vaccine effectiveness and evolving variants: understanding the immunological footprint
Conflict of interest statement
We declare no competing interests.
Comment on
-
Long-term effectiveness of COVID-19 vaccines against infections, hospitalisations, and mortality in adults: findings from a rapid living systematic evidence synthesis and meta-analysis up to December, 2022.Lancet Respir Med. 2023 May;11(5):439-452. doi: 10.1016/S2213-2600(23)00015-2. Epub 2023 Feb 10. Lancet Respir Med. 2023. PMID: 36780914 Free PMC article.
Similar articles
-
Analysis of Vaccine Effectiveness Against COVID-19 and the Emergence of Delta and Other Variants of Concern in Utah.JAMA Netw Open. 2021 Dec 1;4(12):e2140906. doi: 10.1001/jamanetworkopen.2021.40906. JAMA Netw Open. 2021. PMID: 34940869 Free PMC article.
-
Extended reporting guidance for vaccine effectiveness studies for variants of concern for COVID-19.Vaccine. 2022 May 11;40(22):2986-2987. doi: 10.1016/j.vaccine.2022.04.005. Epub 2022 Apr 7. Vaccine. 2022. PMID: 35443916 Free PMC article. No abstract available.
-
Host factors and vaccine efficacy: Implications for COVID-19 vaccines.J Med Virol. 2022 Apr;94(4):1330-1335. doi: 10.1002/jmv.27485. Epub 2021 Dec 7. J Med Virol. 2022. PMID: 34845730 Free PMC article. Review.
-
Viral replication dynamics could critically modulate vaccine effectiveness and should be accounted for when assessing new SARS-CoV-2 variants.Influenza Other Respir Viruses. 2022 Mar;16(2):366-367. doi: 10.1111/irv.12961. Epub 2022 Jan 10. Influenza Other Respir Viruses. 2022. PMID: 35014184 Free PMC article. No abstract available.
-
Understanding and Improving Vaccine Effectiveness Estimates in the Age of Widespread Background Immunity: A Step Toward Improved Science Communication.Clin Infect Dis. 2023 May 3;76(9):1535-1538. doi: 10.1093/cid/ciad124. Clin Infect Dis. 2023. PMID: 36883583 Review.
Cited by
-
SARS-CoV-2-infection- and vaccine-induced antibody responses are long lasting with an initial waning phase followed by a stabilization phase.Immunity. 2024 Mar 12;57(3):587-599.e4. doi: 10.1016/j.immuni.2024.01.017. Epub 2024 Feb 22. Immunity. 2024. PMID: 38395697 Free PMC article.
-
Original COVID-19 priming regimen impacts the immunogenicity of bivalent BA.1 and BA.5 boosters.Nat Commun. 2024 May 18;15(1):4224. doi: 10.1038/s41467-024-48414-x. Nat Commun. 2024. PMID: 38762522 Free PMC article. Clinical Trial.
-
Dynamic Changes and Trends of SARS-CoV-2 Antibodies Induced by Infection and Vaccination Across Multiple Time Points.J Med Virol. 2025 Jan;97(1):e70161. doi: 10.1002/jmv.70161. J Med Virol. 2025. PMID: 39780477 Free PMC article.
-
The immunological impact of revaccination in a hybrid-immune world.Front Immunol. 2025 Jun 9;16:1588259. doi: 10.3389/fimmu.2025.1588259. eCollection 2025. Front Immunol. 2025. PMID: 40552302 Free PMC article. Review.
-
Impact of COVID-19 Vaccination on Hospitalization and Mortality: A Comparative Analysis of Clinical Outcomes During the Early Phase of the Pandemic.Infect Dis Rep. 2025 Jun 27;17(4):74. doi: 10.3390/idr17040074. Infect Dis Rep. 2025. PMID: 40700321 Free PMC article.
References
-
- Wu N, Joyal-Desmarais K, Ribeiro PAB, et al. Long-term effectiveness of COVID-19 vaccines against infections, hospitalisations, and mortality in adults: findings from a rapid living systematic evidence synthesis and meta-analysis up to December, 2022. Lancet Respir Med. 2023 doi: 10.1016/S2213-2600(23)00015-2. published online Feb 10. - DOI - PMC - PubMed
-
- Khoury DS, Cromer D, Reynaldi A, et al. Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection. Nat Med. 2021;27:1205–1211. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical